Answers are grounded in this paper and cite their sources.
BACKGROUND: Bisphenol S (BPS) is a widespread BPA substitute with emerging immunotoxicity; this review synthesizes zebrafish and rodent experimental evidence to clarify BPS-induced inflammation. METHODS: Narrative synthesis of experimental studies in zebrafish and rodent models, focusing on molecular pathways, organ-level effects, and exposure timing. RESULTS: Across models, BPS consistently activates an oxidative stress-mediated NF-κB axis with increased ROS, lipid peroxidation, and upregulation of TNF-α, IL-1β, and IL-6; chronic and developmental low-to-moderate exposures produced stronger inflammatory phenotypes than acute high doses. CONCLUSIONS: Convergent mechanistic and pathological findings strengthen the weight of evidence for BPS immunotoxicity and support targeted monitoring and controls; key research gaps include inflammasome activation, receptor mechanisms, sex differences, mixture effects, epigenetic regulation, and standardization.
No takes yet. Share an insight, caveat, or question.
Azhan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: